PEG-Mediated Synthesis of Highly Dispersive Multifunctional Superparamagnetic Nanoparticles: Their Physicochemical Properties and Function In Vivo
Source abstract
Abstract
Multifunctional superparamagnetic nanoparticles have been developed for a wide range of applications in nanomedicine, such as serving as tumor-targeted drug carriers and molecular imaging agents. To function in vivo, the development of these novel materials must overcome several challenging requirements including biocompatibility, stability in physiological solutions, nontoxicity, and the ability to traverse biological barriers. Here we report a PEG-mediated synthesis process to produce well-dispersed, ultrafine, and highly stable iron oxide nanoparticles for in vivo applications. Utilizing a biocompatible PEG coating bearing amine functional groups, the produced nanoparticles serve as an effective platform with the ability to incorporate a variety of targeting, therapeutic, or imaging ligands. In this study, we demonstrated tumor-specific accumulation of these nanoparticles through both magnetic resonance and optical imaging after conjugation with chlorotoxin, a peptide with high affinity toward tumors of the neuroectodermal origin, and Cy5.5, a near-infrared fluorescent dye. Furthermore, we performed preliminary biodistribution and toxicity assessments of these nanoparticles in wild-type mice through histological analysis of clearance organs and hematology assay, and the results demonstrated the relative biocompatibility of these nanoparticles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials Science & Engineering
Department of Bioengineering
Department of Radiology
and Department of Neurological Surgery, University of Washington, Seattle, Washington 98195
Seattle Children’s Hospital & Regional Medical Center, Seattle, Washington 98105
References (42)
Show source-provided references
1. Veiseh O. · Nano Lett. · 2005 · 5 · 100310.1021/nl0502569 ↗
2. Sun C. · J. Biomed. Mater. Res., Part A · 2006 · 78 · 55010.1002/jbm.a.30781 ↗
3. Sun C. · Small · 2008 · 4 · 37210.1002/smll.200700784 ↗
4. Harisinghani M. G. · N. Engl. J. Med. · 2003 · 348 · 249110.1056/NEJMoa022749 ↗
5. Medarova Z. · Nat. Med. · 2007 · 13 · 37210.1038/nm1486 ↗
6. Gunn J. · Small · 2008 · 4 · 71210.1002/smll.200701103 ↗
7. Veiseh O. · Biomaterials · 2009 · 30 · 64910.1016/j.biomaterials.2008.10.003 ↗
8. Lewin M. · Nat. Biotechnol. · 2000 · 18 · 41010.1038/74464 ↗
9. Sun C. · Adv. Drug Delivery Rev. · 2008 · 60 · 125210.1016/j.addr.2008.03.018 ↗
10. Veiseh O. · Cancer Res. · 2009 · 69 · 620010.1158/0008-5472.CAN-09-1157 ↗
11. Weissleder R. · Adv. Drug Delivery Rev. · 1995 · 16 · 32110.1016/0169-409X(95)00033-4 ↗
12. Widder K. J. · Proc. Natl. Acad. Sci. U.S.A. · 1981 · 78 · 57910.1073/pnas.78.1.579 ↗
13. Lin H. · J. Appl. Polym. Sci. · 2003 · 87 · 123910.1002/app.11520 ↗
14. Lee S. J. · Colloids Surf. A · 2005 · 255 · 1910.1016/j.colsurfa.2004.12.019 ↗
15. Shen T. · Magn. Reson. Med. · 1993 · 29 · 59910.1002/mrm.1910290504 ↗
16. Zhang Y. · Biomaterials · 2002 · 23 · 155310.1016/S0142-9612(01)00267-8 ↗
17. Lee H. S. · J. Magn. Magn. Mater. · 2005 · 293 · 10210.1016/j.jmmm.2005.01.049 ↗
18. Kohler N. · J. Am. Chem. Soc. · 2004 · 126 · 720610.1021/ja049195r ↗
19. Larsen E. K. · ACS Nano · 2009 · 3 · 194710.1021/nn900330m ↗
20. Xie J. · Adv. Mater. · 2007 · 19 · 316310.1002/adma.200701975 ↗
21. De Palma R. · Chem. Mater. · 2007 · 19 · 182110.1021/cm0628000 ↗
22. Zhang T. R. · Nano Lett. · 2007 · 7 · 320310.1021/nl071928t ↗
23. DeBin J. A. · Toxicon · 1991 · 29 · 140310.1016/0041-0101(91)90128-E ↗
24. Kachra Z. · Clin. Exp. Metastasis · 1999 · 17 · 55510.1023/A:1006760632766 ↗
25. Deshane J. · J. Biol. Chem. · 2003 · 278 · 413510.1074/jbc.M205662200 ↗
26. Lyons S. A. · Glia · 2002 · 39 · 16210.1002/glia.10083 ↗
27. Veiseh M. · Cancer Res. · 2007 · 67 · 688210.1158/0008-5472.CAN-06-3948 ↗
28. Sun C. · Nanomedicine · 2008 · 3 · 49510.2217/17435889.3.4.495 ↗
29. Kanan S. A. · Langmuir · 2002 · 18 · 662310.1021/la0203133 ↗
30. Tartaj P. · J. Phys. D · 2003 · 36 · R18210.1088/0022-3727/36/13/202 ↗
31. Fang C. · J. Mater. Chem. · 2009 · 19 · 625810.1039/b902182e ↗
32. MNneil S. E. · J. Leukocyte Biol. · 2005 · 78 · 58510.1189/jlb.0205074 ↗
33. Veiseh O. · Small · 2009 · 5 · 25610.1002/smll.200800646 ↗
34. Maeda H. · J. Controlled Release · 2000 · 65 · 27110.1016/S0168-3659(99)00248-5 ↗
35. Maeda H. · Adv. Enzyme Regul. · 2001 · 41 · 18910.1016/S0065-2571(00)00013-3 ↗
36. Frangioni J. V. · Curr. Opin. Chem. Biol. · 2003 · 7 · 62610.1016/j.cbpa.2003.08.007 ↗
37. Moore A. · Radiology · 2000 · 214 · 56810.1148/radiology.214.2.r00fe19568 ↗
38. Loeb W. F. · 1996 · 3
39. Wolford S. T. · J. Toxicol. Environ. Health · 1986 · 18 · 16110.1080/15287398609530859 ↗
40. Jain N. C. · 1993
41. Butterworth M. D. · Colloids Surf. A · 2001 · 179 · 9310.1016/S0927-7757(00)00633-6 ↗
42. Arkles, B.Silane Coupling Agents: Connecting Across Boundaries V2.0.Gelest, Inc.:Morrisville, PA, 2006; p56.